Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia

被引:238
作者
Dennesen, PJW
van der Ven, AJAM
Kessels, AGH
Ramsay, C
Bonten, MJM
机构
[1] Univ Utrecht Hosp, Div Infect Dis & AIDS, Dept Internal Med, Utrecht, Netherlands
[2] Univ Hosp Maastricht, Dept Med Microbiol, Maastricht, Netherlands
[3] Univ Hosp Maastricht, Dept Med Technol Assessment, Maastricht, Netherlands
[4] Univ Hosp Maastricht, Dept Surg, Maastricht, Netherlands
关键词
D O I
10.1164/ajrccm.163.6.2007020
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Although recommended durations of antimicrobial therapy for ventilator-associated pneumonia (VAP) range from 7 to 21 d, these are not based on prospective studies and little is known about the resolution of symptoms after start of antibiotics. Resolution of these symptoms was investigated in 27 patients. VAP was diagnosed on clinical, radiographic, and microbiological criteria, including quantitative cultures of bronchoalveolar lavage. All patients received appropriate antibiotic therapy. Highest temperatures, leukocyte counts, Pa-O2/Fl(O2) ratios, and semiquantitative cultures of endotracheal aspirates were recorded from start of therapy until Day 14. Resolution was defined as the first day that these parameters fulfilled the following definition: temperature less than or equal to 38 degreesC, leukocytes less than or equal to 10 x 10(9)/L, Pa-O2/Fl(O2) ratio greater than or equal to 25 kPa, and no or +1 of bacterial growth of etiologic pathogens in cultures of endotracheal aspirate. VAP was caused by Enterobacteriaceae (n = 14), P. aeruginosa (n = 7), S. aureus (n = 6), H. influenzae (n = 3), and S. pneumoniae (n = 1). ii. influenzae and S. pneumoniae were eradicated from tracheal aspirates, whereas Enterobacteriaceae, S. aureus, and P, aeruginosa persisted, despite in vitro susceptibility to antibiotics administered. Significant improvements were observed for all clinical parameters, most apparently within the first 6 d after start of antibiotics. Newly acquired colonization, especially with P. aeruginosa and Enterobacteriaceae, occurred in the second week of therapy. Six patients developed a recurrent episode of VAP, four of them with P, aeruginosa. Clinical responses to therapy for VAP occur within the first 6 d of therapy, endotracheal colonization with Cram-negative bacteria persists despite susceptibility to therapy, and acquired colonization usually occurs in the second week of therapy and frequently precedes a recurrent episode.
引用
收藏
页码:1371 / 1375
页数:5
相关论文
共 21 条
[1]
Indications for antibiotic use in ICU patients: a one-year prospective surveillance [J].
Bergmans, DCJJ ;
Bonten, MJM ;
Gaillard, CA ;
vanTiel, FH ;
vanderGeest, S ;
deLeeuw, PW ;
Stobberingh, EE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (04) :527-535
[2]
Reproducibility of quantitative cultures of endotracheal aspirates from mechanically ventilated patients [J].
Bergmans, DCJJ ;
Bonten, MJM ;
DeLeeuw, PW ;
Stobberingh, EE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) :796-798
[3]
THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[4]
Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units -: Implications for infection control [J].
Bonten, MJM ;
Bergmans, DCJJ ;
Speijer, H ;
Stobberingh, EE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (04) :1212-1219
[5]
Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use [J].
Bonten, MJM ;
Bergmans, DCJJ ;
Stobberingh, EE ;
vanderGeest, S ;
DeLeeuw, PW ;
vanTiel, FH ;
Gaillard, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (06) :1820-1824
[6]
BONTEN MJM, 1994, CRIT CARE MED, V22, P1683
[7]
Brewer C, 1996, CHEST, V109, P1019
[8]
Duguid JP., 1975, Medical Microbiology, V12
[9]
Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia -: A randomized trial [J].
Fagon, JY ;
Chastre, J ;
Wolff, M ;
Gervais, C ;
Parer-Aubas, S ;
Stéphan, F ;
Similowski, T ;
Mercat, A ;
Diehl, JL ;
Sollet, JP ;
Tenaillon, A .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (08) :621-+
[10]
NOSOCOMIAL PNEUMONIA IN VENTILATED PATIENTS - A COHORT STUDY EVALUATING ATTRIBUTABLE MORTALITY AND HOSPITAL STAY [J].
FAGON, JY ;
CHASTRE, J ;
HANCE, AJ ;
MONTRAVERS, P ;
NOVARA, A ;
GIBERT, C .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (03) :281-288